Literature DB >> 32663365

Bone Density and Trabecular Morphology at Least 10 Years After Gastric Bypass and Gastric Banding.

Katherine G Lindeman1, Claire C Rushin1, Michael C Cheney1, Mary L Bouxsein1,2,3, Matthew M Hutter2,4, Elaine W Yu1,2.   

Abstract

Roux-en-Y gastric bypass (RYGB) instigates high-turnover bone loss in the initial 5 years after surgery, whereas skeletal changes after adjustable gastric banding (AGB) are less pronounced. Long-term skeletal data are scarce, and the mechanisms of bone loss remain unclear. We sought to examine bone density and microarchitecture in RYGB and AGB patients a decade after surgery and to determine whether prior published reports of bone loss represent an appropriate adaptation to new postsurgical weight. In this cross-sectional study, 25 RYGB and 25 AGB subjects who had bariatric surgery ≥10 years ago were matched 1:1 with nonsurgical controls for age, sex, and current body mass index (BMI). We obtained bone mineral density (BMD) by dual-energy X-ray absorptiometry (DXA), volumetric BMD and microarchitecture by high-resolution peripheral quantitative computed tomography (HR-pQCT), trabecular morphology by individual trabecular segmentation, and metabolic bone laboratory results. As compared with BMI-matched controls, RYGB subjects had significantly lower hip BMD, and lower total volumetric BMD at the distal radius and tibia. Substantial deficits in cortical and trabecular microarchitecture were observed in the RYGB group compared to controls, with reduced trabecular plate bone volume fraction and estimated failure load at both the radius and tibia, respectively. Bone turnover markers CTX and P1NP were 99% and 77% higher in the RYGB group than controls, respectively, with no differences in serum calcium, 25-hydroxyvitamin D, or parathyroid hormone. In contrast, the AGB group did not differ from their BMI-matched controls in any measured bone density, microarchitecture, or laboratory parameter. Thus, RYGB, but not AGB, is associated with lower than expected hip and peripheral BMD for the new weight setpoint, as well as deleterious changes in bone microarchitecture. These findings suggest that pathophysiologic processes other than mechanical unloading or secondary hyperparathyroidism contribute to bone loss after RYGB, and have important clinical implications for the long-term care of RYGB patients.
© 2020 American Society for Bone and Mineral Research. © 2020 American Society for Bone and Mineral Research.

Entities:  

Keywords:  BARIATRIC SURGERY; BONE DENSITY; BONE MICROARCHITECTURE; INDIVIDUAL TRABECULAR SEGMENTATION; SKELETAL UNLOADING

Mesh:

Year:  2020        PMID: 32663365     DOI: 10.1002/jbmr.4112

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  6 in total

1.  Zoledronic acid for prevention of bone loss in patients receiving bariatric surgery.

Authors:  Yi Liu; Maya M Côté; Michael C Cheney; Katherine G Lindeman; Claire C Rushin; Matthew M Hutter; Elaine W Yu
Journal:  Bone Rep       Date:  2021-03-02

Review 2.  Bone Response to Weight Loss Following Bariatric Surgery.

Authors:  Chiara Mele; Marina Caputo; Alice Ferrero; Tommaso Daffara; Beatrice Cavigiolo; Daniele Spadaccini; Antonio Nardone; Flavia Prodam; Gianluca Aimaretti; Paolo Marzullo
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-07       Impact factor: 6.055

Review 3.  Changes in volumetric bone mineral density and bone quality after Roux-en-Y gastric bypass: A meta-analysis with meta-regression.

Authors:  Alba Hernández-Martínez; Lucas Veras; Giorjines Boppre; Alberto Soriano-Maldonado; José Oliveira; Florêncio Diniz-Sousa; Hélder Fonseca
Journal:  Obes Rev       Date:  2022-06-03       Impact factor: 10.867

4.  Long-term Bone Loss and Deterioration of Microarchitecture After Gastric Bypass in African American and Latina Women.

Authors:  Alexandra Krez; Sanchita Agarwal; Mariana Bucovsky; Donald J McMahon; Yizhong Hu; Marc Bessler; Beth Schrope; Angela Carrelli; Shannon Clare; Xiang-Dong Edward Guo; Shonni J Silverberg; Emily M Stein
Journal:  J Clin Endocrinol Metab       Date:  2021-03-25       Impact factor: 5.958

Review 5.  Managing fragility fractures during the COVID-19 pandemic.

Authors:  Nicola Napoli; Ann L Elderkin; Douglas P Kiel; Sundeep Khosla
Journal:  Nat Rev Endocrinol       Date:  2020-09       Impact factor: 43.330

6.  Time-Restricted Eating for 12 Weeks Does Not Adversely Alter Bone Turnover in Overweight Adults.

Authors:  Andrea J Lobene; Satchidananda Panda; Douglas G Mashek; Emily N C Manoogian; Kathleen M Hill Gallant; Lisa S Chow
Journal:  Nutrients       Date:  2021-03-31       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.